Superficial esophageal squamous carcinoma serum exosome miRNAs expression profile, detection kit and application

The invention discloses a superficial esophageal squamous carcinoma serum exosome miRNAs expression profile, a detection kit and application of the superficial esophageal squamous carcinoma serum exosome miRNAs. The expression profile is mainly composed of hsa-miR-30a-5p and hsa-miR-99a-5p which are...

Full description

Saved in:
Bibliographic Details
Main Authors YAO XIANGYI, FENG YADONG, ZHANG YOUYU, SHI RUIHUA
Format Patent
LanguageChinese
English
Published 07.04.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention discloses a superficial esophageal squamous carcinoma serum exosome miRNAs expression profile, a detection kit and application of the superficial esophageal squamous carcinoma serum exosome miRNAs. The expression profile is mainly composed of hsa-miR-30a-5p and hsa-miR-99a-5p which are expressed in an up-regulation mode, and hsa-miR-185-5p, hsa-miR-7-5p and hsa-miR-96-5p which are expressed in a down-regulation mode. The invention discloses a serum exosome miRNAs expression profile of a superficial esophageal squamous cell carcinoma patient, a differential expression miRNAs molecular map between the superficial esophageal squamous cell carcinoma patient and healthy people is defined, and a biological marker for early diagnosis, prognosis evaluation and curative effect prediction of the superficial esophageal squamous cell carcinoma disease is screened from the molecular map. A superficial esophageal squamous carcinoma cell characteristic miRNAs molecular expression map is analyzed; the correlati
Bibliography:Application Number: CN202210935268